Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 390

Results For "NDA"

5529 News Found

De Nora and Aclarity sign agreement to deploy PFAS destroying technology
News | December 15, 2022

De Nora and Aclarity sign agreement to deploy PFAS destroying technology

The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally


Hovione and GEA collaborate to advance continuous tableting
News | December 15, 2022

Hovione and GEA collaborate to advance continuous tableting

This partnership stemmed from a successful customer-supplier relationship spanning several years.


Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
News | December 14, 2022

Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility

The investment will enable the company to enter European markets as well as enhance margins in current markets


AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
People | December 14, 2022

AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD

Sanjeev is currently the Country President for AstraZeneca Malaysia


JB Pharma to buy Glenmark's ‘Razel’ for Rs. 314 crore in India and Nepal
News | December 14, 2022

JB Pharma to buy Glenmark's ‘Razel’ for Rs. 314 crore in India and Nepal

The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy


US Federal Court dismisses cancer linkage associated with Zantac
News | December 13, 2022

US Federal Court dismisses cancer linkage associated with Zantac

The current ruling will assure the safety of the use of Ranitidine for Indian patients


Inclusion of Yoga in the treatment of breast cancer patients is highly beneficial
News | December 13, 2022

Inclusion of Yoga in the treatment of breast cancer patients is highly beneficial

The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama


Alembic receives EIR for oncology injectable formulation facility at Panelav
Drug Approval | December 12, 2022

Alembic receives EIR for oncology injectable formulation facility at Panelav

This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA


Alembic receives USFDA final Approval for Desonide Cream
Drug Approval | December 12, 2022

Alembic receives USFDA final Approval for Desonide Cream

Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA


Zydus receives USFDA approval to market Silodosin and Pregabalin capsules
Drug Approval | December 12, 2022

Zydus receives USFDA approval to market Silodosin and Pregabalin capsules

Silodosin capsules treat signs and symptoms of an enlarged prostate gland